NCT05228015 · Interventional trial
Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors
Overall registry status Terminated
Phase 1
Conditions Epithelioid Hemangioendothelioma (EHE), Malignant Pleural Mesothelioma (MPM), NF2 Deficiency, NF2 Deficient Mesothelioma, Other NF2 Deficient Solid Tumors and Solid Tumors with YAP1/TAZ Fusion Genes, Solid Tumor, Solid Tumors, Adult, YAP1 or TAZ Gene Fusions
Delaware Valley sites
- Sidney Kimmel Cancer Center at Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
- University of Pennsylvania Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory